Can therapeutic drug monitoring improve pharmacotherapy of HIV infection in adolescents? - Wikidata - awgldk - TriplyDB

Can therapeutic drug monitoring improve pharmacotherapy of HIV infection in adolescents?

Can therapeutic drug monitoring improve pharmacotherapy of HIV infection in adolescents?

http://www.wikidata.org/entity/Q33914723

about

Perinatally acquired HIV infection in adolescents from sub-Saharan Africa: a review of emerging challenges Asking the right questions: developing evidence-based strategies for treating HIV in women and children Pharmacokinetics of lopinavir/ritonavir crushed versus whole tablets in children.Effect of Lopinavir and Nevirapine Concentrations on Viral Outcomes in Protease Inhibitor-experienced HIV-infected Children Antiretroviral drugs in pediatric HIV-infected patients: pharmacokinetic and practical challenges.Functional polymorphism of CYP2B6 G15631T is associated with hematologic and cytogenetic response in chronic myeloid leukemia patients treated with imatinib.Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult life.Pharmacokinetics of lopinavir determined with an ELISA test in youths with perinatally acquired HIV.Atazanavir-bilirubin interaction: a pharmacokinetic-pharmacodynamic model.Extended mathematical model for "in vivo" quantification of the interaction betweeen atazanavir and bilirubin.

P2860

Q27022471-51C1F11D-E1A2-4DB8-9D6B-B92A101ED1C8 Q28743488-04A020A2-099C-4680-85A5-31E146B3D2E3 Q35488671-D7468087-9CAE-4650-B3E6-611A86DE0E95 Q37513856-04C8ACE8-34A3-4807-BBDE-D04FAC2DD6EA Q37866289-1BA5952D-DFB6-4DB1-B711-3803C2827B1E Q39123115-5E5283CC-4F13-4A96-A535-DBB84D5DC562 Q41505058-E7A59880-8E27-4B49-9C03-346BC5CDB67E Q42248475-11B2F8A0-6EA6-4086-810B-D7839260F739 Q42263920-10EF85BD-017B-4B03-9E47-7674E05030F3 Q43699242-E6C0B3B2-50CC-4807-8B0D-417E1ECB7466

P2860

Can therapeutic drug monitoring improve pharmacotherapy of HIV infection in adolescents?

http://www.wikidata.org/entity/Q33914723

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Can therapeutic drug monitoring improve pharmacotherapy of HIV infection in adolescents?

@ast

Can therapeutic drug monitoring improve pharmacotherapy of HIV infection in adolescents?

@en

type

label

Can therapeutic drug monitoring improve pharmacotherapy of HIV infection in adolescents?

@ast

Can therapeutic drug monitoring improve pharmacotherapy of HIV infection in adolescents?

@en

prefLabel

Can therapeutic drug monitoring improve pharmacotherapy of HIV infection in adolescents?

@ast

Can therapeutic drug monitoring improve pharmacotherapy of HIV infection in adolescents?

@en

P1433

Q33914723-858A35A9-74E3-4268-A25C-2B8DCBA2E3E3

P1476

Q33914723-59AE290E-0C9E-42A2-9818-0DD80EEBC2B4

P2093

Q33914723-02C0FE71-0886-4FA1-8C62-C3147D6613BA

Q33914723-08AFDAB1-41E9-4763-BF40-9C1F3711BBE1

Q33914723-0E6F57DB-D73C-469D-AD7F-C2495BFC38FB

Q33914723-13493050-6D47-418F-9617-B9B7F15E68A3

Q33914723-41903577-3BDC-48F8-8F0F-E757C364D8CA

P2860

Q33914723-0938CCB8-3D00-4834-83DA-8774F539E004

Q33914723-0ED7C749-9727-4130-99E8-5F3B8DF4EE5D

Q33914723-0F4F0548-50B8-491D-9BC3-6CA0077BE5DC

Q33914723-11CF76CC-830F-4BE3-8B59-1C037F60BFC8

Q33914723-1634638B-AA96-49F6-B290-B41AF5EF2601

Q33914723-167550FE-4CD2-4248-A758-942E60F5B3AD

Q33914723-19C1F950-60E7-4EFA-9EA6-C60E9464EA9B

Q33914723-202FF777-13D2-4741-BC7E-1555EA6303CB

Q33914723-2D965670-5802-4974-BC06-F4756FC26E55

Q33914723-34D399C1-11CE-4223-A3C3-653E7F8C91E6

P304

Q33914723-4C0933FE-48C2-42C0-B155-C7DA64CAF14B

P31

Q33914723-2865766B-86B7-4B63-99B0-3F07F3C9CD62

P356

Q33914723-1DEA10A0-D3A0-44FB-8D75-3B6BFCE685E0

P433

Q33914723-8743737F-5522-418C-8B9F-D23D9E8A2849

P478

Q33914723-2DEECD24-BE9A-4DBC-81F5-E725260EEC6A

P50

Q33914723-5AEA427E-ABF9-46E1-8127-8869BABD025A

P577

Q33914723-DAC77239-2C8D-4A16-B4AD-196126535DD7

P698

Q33914723-D8487BE5-A927-4E0F-BD2E-9943FA2087B9

P921

Q33914723-6114320F-54D7-4447-B96C-4B18A36DD615

Q33914723-8B191C60-CCF3-4811-B936-BACEFC04F9ED

P932

Q33914723-98B3B394-C722-49F2-9CB5-BB3AC9EAC7D2

P356

FTD.0B013E3181DCA14B

P1433

Therapeutic Drug Monitoring

P1476

Can therapeutic drug monitoring improve pharmacotherapy of HIV infection in adolescents?

@en

P2093

John N van den Anker

http://www.w3.org/2001/XMLSchema#string

Michael N Neely

http://www.w3.org/2001/XMLSchema#string

Nick Mordwinkin

http://www.w3.org/2001/XMLSchema#string

Ron H van Schaik

http://www.w3.org/2001/XMLSchema#string

Steven J Soldin

http://www.w3.org/2001/XMLSchema#string

P2860

Predictive value of known and novel alleles of CYP2B6 for efavirenz plasma concentrations in HIV-infected individuals.

Personalized therapeutics: HIV treatment in adolescents

Patient-related risks for nonadherence to antiretroviral therapy among HIV-infected youth in the United States: a study of prevalence and interactions

Tenofovir disoproxil fumarate: a review of its use in the management of HIV infection.

Therapeutic drug monitoring in HIV infection: current status and future directions.

A review of the pharmacokinetics of abacavir.

Prevalence of CYP2B6 alleles in malaria-endemic populations of West Africa and Papua New Guinea

Therapeutic drug monitoring in children with HIV/AIDS.

Population pharmacokinetics of lopinavir in combination with ritonavir in HIV-1-infected patients

Integrating adherence to highly active antiretroviral therapy into children's daily lives: a qualitative study.

P304

273-281

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/FTD.0B013E3181DCA14B

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Natella Rakhmanina

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20445485

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy

P932

2886015

http://www.w3.org/2001/XMLSchema#string